Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21−0.07 (-5.47%)
Close on Nov 13, 2026Market cap $10.90MP/E –Yield –
Lisata Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Lisata Therapeutics's total debt was $0 at Dec 31, 2017. For fiscal 2017 it was $0, down 100.0% from the year before. The highest annual figure on record is $15.00M in fiscal 2014.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $0 | -100.0% |
| FY2016 | Dec 31, 2016 | $5.65M | -62.3% |
| FY2015 | Dec 31, 2015 | $15.00M | 0.0% |
| FY2014 | Dec 31, 2014 | $15.00M | – |
| FY2013 | Dec 31, 2013 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $171.53K | – |
| FY2011 | Dec 31, 2011 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2017 | Dec 31, 2017 | $0 | -100.0% |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $4.89M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.65M | – |
See a number that looks wrong?